These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3968452)

  • 1. Failed rubella immunization in adults: association with immunologic and virological abnormalities.
    Tingle AJ; Chantler JK; Kettyls GD; Larke RP; Schulzer M
    J Infect Dis; 1985 Feb; 151(2):330-6. PubMed ID: 3968452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.
    Mitchell LA; Zhang T; Ho M; Décarie D; Tingle AJ; Zrein M; Lacroix M
    J Clin Microbiol; 1992 Jul; 30(7):1841-7. PubMed ID: 1629342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
    Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
    Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low level rubella immunity detected by ELISA and specific lymphocyte transformation.
    Buimovici-Klein E; O'Beirne AJ; Millian SJ; Cooper LZ
    Arch Virol; 1980; 66(4):321-7. PubMed ID: 7447708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine.
    Cusi MG; Rossolini GM; Cellesi C; Valensin PE
    Arch Virol; 1988; 101(1-2):25-33. PubMed ID: 3046563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro lymphocyte reactivity to rubella antigen following vaccination.
    Heigl Z; Wasserman J; Forsgren M
    Scand J Infect Dis; 1980; 12(1):13-20. PubMed ID: 6988953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody response to live rubella vaccination and its clinical meanings].
    Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella vaccines and the immunity gap.
    Andre FE; Florent G; du Pan RM
    Lancet; 1979 Aug; 2(8139):417-8. PubMed ID: 89471
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune responses to wild and vaccine rubella viruses after rubella vaccination.
    Cusi MG; Metelli R; Valensin PE
    Arch Virol; 1989; 106(1-2):63-72. PubMed ID: 2764728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations.
    Matter L; Kogelschatz K; Germann D
    J Infect Dis; 1997 Apr; 175(4):749-55. PubMed ID: 9086126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell mediated immunity in experimental rubella infections.
    Cappel R
    Arch Virol; 1975; 47(4):375-9. PubMed ID: 1137503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
    J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with a live RA 27/3 strain rubella vaccine (Rudivax), a follow-up study.
    Suni JI; Meurman O; Hirvonen P; Vaheri A
    Vaccine; 1984 Dec; 2(4):281-3. PubMed ID: 6531969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are many women immunized against rubella unnecessarily?
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Mace JE; Hutchinson A
    J Hyg (Lond); 1981 Aug; 87(1):131-8. PubMed ID: 7019319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenge with rubella virus after loss of detectable vaccine-induced antibody.
    Schiff GM; Young BC; Stefanovic' GM; Stamler EF; Knowlton DR; Grundy BJ; Dorsett PH
    Rev Infect Dis; 1985; 7 Suppl 1():S157-63. PubMed ID: 4001723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of rubella antibodies in pregnant women by ELISA and the responses of young women to (rubella vaccines)].
    Tanaka S; Miyazawa H; Watanabe N; Ashiwara Y
    Kansenshogaku Zasshi; 1982 Jul; 56(7):582-7. PubMed ID: 6818295
    [No Abstract]   [Full Text] [Related]  

  • 20. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing.
    Hedman K; Hietala J; Tiilikainen A; Hartikainen-Sorri AL; Räihä K; Suni J; Väänänen P; Pietiläinen M
    J Med Virol; 1989 Apr; 27(4):293-8. PubMed ID: 2656909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.